The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Ruqin Chen, MB, on Lung Cancer Treated With Immune Checkpoint Inhibitors: Predicting Survival Outcomes

Posted: Friday, March 29, 2019

Ruqin Chen, MB, of the Mayo Clinic Florida, discusses the clinical and molecular features associated with good survival outcomes and those associated with poor prognoses in patients with lung cancer treated with immune checkpoint inhibitors.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.